NSE: SUMICHEM · BSE: 542920
SUMITOMO CHEM INDIA LTD
Sells crop protection chemicals — herbicides, insecticides and fungicides — to Indian farmers through branded products including Sumimax, Excalia Max and Lentigo, while exporting to more than 50 countries. In FY26, total revenue was ₹3,238.315 crore with PAT of ₹542.975 crore and an EBITDA margin of 20.7%. Per the disclosed segment split (year to March 2022), agro chemicals contributed 92.7% of segment revenue at ₹2,840.525 crore and "Others" 7.3% at ₹224.074 crore; FY26 investor reporting notes that domestic business grew 4% while exports declined 1%, with Africa up 26-30% YoY and herbicides up 19% for the year. Operations sit on 5 manufacturing plants and 7 offices in India, with a workforce supporting domestic field activity and export markets. Materials — raw and packaging inputs — are the dominant cost at 51% of revenue, followed by employee cost at 8.5% and other operating expenses at 12.9%. Growth capex underway includes a ₹500–600 crore Dahej greenfield over five years, ₹8–10 crore for Excalia Max manufacturing at Tarapur by March 2027, and a doubling of Bhavnagar capacity by end-CY2026. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Agro Chemicals (93%), Others (7%). Cyclical, monsoon-driven Indian agrochemical business with growing export footprint
Exhibit 1: Financial summary, FY22–FY26 (all audited; no estimate years)
| ₹ crore · consolidated | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 3,065 | 3,511 | 2,844 | 3,149 | 3,238 |
| EBITDA (ex other income) | 600 | 667 | 475 | 632 | 655 |
| margin % | 19.6 | 19.0 | 16.7 | 20.1 | 20.2 |
| Owners' profit | 424 | 502 | 370 | 505 | 543 |
| EPS, as reported (₹) | 8.49 | 10.06 | 7.40 | 10.13 | 10.88 |
| ROE % · ROCE % | 22.0 · 29.3 | 21.1 · 27.1 | 15.1 · 20.2 | 17.4 · 22.9 | 16.0 · 21.0 |
| Debt / equity (x) | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Cash from operations | 222 | 389 | 760 | 453 | 446 |
| Capex | (114) | (120) | (66) | (29) | (44) |
Exhibit 2: Quarterly performance, last 8 quarters
| ₹ crore | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 988 | 642 | 679 | 1,057 | 930 | 568 | 684 | 1,063 |
| Profit before tax | 260 | 117 | 133 | 241 | 238 | 102 | 148 | 288 |
| Net profit | 193 | 87 | 100 | 178 | 178 | 76 | 111 | 215 |
| EPS (₹) | 3.85 | 1.74 | 2.00 | 3.57 | 3.56 | 1.52 | 2.23 | 4.30 |
Exhibit 3: Peers — basic industry group, by market cap
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| UPL LIMITED | 45,250 | 22.2 | 1.10 | 6.1 | 5.4 | 5.5 | 6.0 | 16.3 |
| PI INDUSTRIES LTD | 31,315 | 26.8 | 2.79 | 14.8 | 11.8 | 14.5 | 8.0 | 25.3 |
| SUMITOMO CHEM INDIA LTD ◆ | 16,716 | 28.9 | 4.93 | 20.8 | 16.0 | 20.8 | 4.1 | 28.9 |
| BAYER CROPSCIENCE LTD | 14,737 | 21.4 | 4.97 | — | 23.2 | 27.3 | — | 22.7 |
| SHARDA CROPCHEM LTD. | 6,172 | 9.9 | 1.97 | 5.0 | 21.7 | 25.2 | 17.1 | 20.5 |
| DHANUKA AGRITECH LTD | 4,008 | 13.7 | 2.86 | 8.9 | 21.2 | 27.0 | 12.7 | 27.4 |
| RALLIS INDIA LTD | 3,557 | 22.2 | 2.10 | 12.0 | 9.7 | 12.5 | — | 0.9 |
| BHAGIRADHA CHEM & INDS L | 2,668 | 97.0 | 3.82 | 48.4 | 2.6 | 2.4 | 11.0 | 16.6 |
Exhibit 4: Where the company sits in its group
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 28.9 | 19.0 | 20 of 24 | 17% |
| P/B | 4.9 | 2.2 | 26 of 28 | 7% |
| ROCE | 20.8 | 12.5 | 5 of 29 | 86% |
| ROE | 16.0 | 9.2 | 5 of 28 | 85% |
| Debt / Equity | 0.0 | 0.3 | 3 of 29 | 93% |
| EBITDA margin | 28.9 | 14.8 | 1 of 28 | 100% |
| Revenue growth | 0.6 | (0.8) | 14 of 28 | 52% |
| Profit growth | 20.4 | 18.1 | 13 of 28 | 56% |
| Market cap | 16716 | 1334 | 3 of 29 | 93% |
Exhibit 5: Filings of the last 90 days, with the measured price reaction
| Date · filing | Category | Importance | Next day % | 5-day % |
|---|---|---|---|---|
| 27 Oct 2026 · Audio recording of October 2026 earnings call uploaded | investor communications | low | — | — |
| 26 Oct 2026 · Q2 revenue and margins fall; H2 outlook remains challenging | investor communications | medium | — | — |
| 26 Oct 2026 · Q2 revenue dips, H1 profit rises on insurance claim | results | high | — | — |
| 26 Oct 2026 · Quarterly sales and profit decline; half-year profit rises | results | high | — | — |
| 19 Oct 2026 · Earnings call for Q2 FY27 on 27 October 2026 | board shareholder meetings | low | — | — |
| 19 Oct 2026 · Earnings call on 27 Oct 2026 to discuss Q2 FY27 results | board shareholder meetings | low | — | — |
| 6 Oct 2026 · Compliance certificate for share dematerialisation for Q2 FY26 | compliance | minimal | — | — |
| 1 Oct 2026 · Board Meeting on 26 Oct 2026 to consider Q2 FY26 results | board shareholder meetings | low | — | — |
| 25 Aug 2026 · Sumitomo Chemical India to meet analysts on Sept 3 via Elara Capital | board shareholder meetings | low | — | — |
| 10 Aug 2026 · Sumitomo Chemical India to meet investors and analysts on 19 August 2026 | board shareholder meetings | low | — | — |
How to read this document
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions | an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
Sources, method and disclosures
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.